Catalyst Wire Dossier Catalyst Wire Dossier

HT-002-01

· Hyundai Pharmaceutical Co., LTD.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HT-002-01, covering 2012-11-08 to 2012-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers [Phase 1]

See pricing